Middle East and Africa (MEA) Kidney Cancer Therapeutics & Diagnostics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The Middle East and Africa (MEA) Kidney Cancer Therapeutics & Diagnostics market is segmented by Cancer Type (Renal Cancer Carcinoma​, Clear Cell Renal Cell Carcinoma, Papillary Renal Cell Carcinoma​, and Others), Component, and Geography

Market Snapshot

CAGR
Study Period: 2018 - 2026
Base Year: 2019
CAGR: 5.2 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The Middle East and Africa Kidney Cancer Therapeutics & Diagnostics market studied was projected to grow with a CAGR of 5.2% over the forecast period. The market will show rapid growth due to the rising number of kidney cancer cases in the region and the increasing R&D expenditure of pharmaceutical companies. Excessive smoking, an increase in obesity due to longevity, and increased intake of alcohol are some of the causes of kidney cancer in the region. According to the Global Cancer Observatory, in Saudi Arabia there are 830 new kidney cancer cases were registered in 2018, furthermore, 249 people were died due to the diseases. Though the prevalence of kidney cancer cases in the region is less compared to the other region of the world, the incidence is still increasing from past years due to the change in lifestyle. Furthermore, the high cost associated with the treatment is restraining the market.

Scope of the report

As per the scope of the report, kidney cancer is a type of cancer which starts in kidney cells. The kidney cancer therapeutics and diagnostics involves therapy and diagnostics methods that are used for the treatment of renal cancer. The drugs are used for the treatment of various type of kidney cancers.

By Cancer Type
Renal Cancer Carcinoma​
Clear Cell Renal Cell Carcinoma
Papillary Renal Cell Carcinoma​
Other Kidney Cancers
By Component
Drugs
Therapeutic Class
Pharmacologic Class
Diagnostics
Biopsy
Imaging Tests
Others
Geography
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa

Report scope can be customized per your requirements. Click here.

Key Market Trends

Clear cell RCC is Expected to be the Largest Growing Segment in the Kidney Cancer Therapeutics & Diagnostics Market

Clear cell renal cell carcinoma, or ccRCC, is a type of kidney cancer. and is named after how the tumor looks under the microscope. There are various treatments for people with ccRCC include surgery, immunotherapy, and targeted therapy.

Targeted therapy targets the changes in cancer cells that help them grow, divide, and spread. Some targeted therapies that are used to treat clear cell renal carcinoma include cabozantinib, axitinib, sunitinib, sorafenib, and pazopanib. According to the Global Burden of Diseases report 2017, the number of incident kidney cancer cases of the Middle East and Africa are recorded to be 15,082. According to Globocan, in 2018, 1,077 new kidney cancer cases were diagnosed, and 582 deaths were reported due to kidney cancer in South Africa. The growing incidence of the early diagnosis and treatment of these cancers is boosting the segment growth.

South Kidney

To understand key trends, Download Sample Report

Competitive Landscape

The Middle East and Africa Kidney Cancer Therapeutics & Diagnostics market is moderately competitive and consists of several major players. Some of the companies which are currently dominating the market are Abbott Laboratories, Bayer AG, Bristol Myers Squibb Company, F. Hoffmann-La Roche, Amgen Inc., Merck & Co. Inc.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Rising Number of Kidney Cancer Cases

      2. 4.2.2 Increased R&D Expenditure of Pharmaceutical Companies

    3. 4.3 Market Restraints

      1. 4.3.1 High Cost Associated with Treatment

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Cancer Type

      1. 5.1.1 Renal Cancer Carcinoma​

      2. 5.1.2 Clear Cell Renal Cell Carcinoma

      3. 5.1.3 Papillary Renal Cell Carcinoma​

      4. 5.1.4 Other Kidney Cancers

    2. 5.2 By Component

      1. 5.2.1 Drugs

        1. 5.2.1.1 Therapeutic Class

        2. 5.2.1.2 Pharmacologic Class

      2. 5.2.2 Diagnostics

        1. 5.2.2.1 Biopsy

        2. 5.2.2.2 Imaging Tests

        3. 5.2.2.3 Others

    3. 5.3 Geography

      1. 5.3.1 Middle-East and Africa

        1. 5.3.1.1 GCC

        2. 5.3.1.2 South Africa

        3. 5.3.1.3 Rest of Middle-East and Africa

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Abbott Laboratories

      2. 6.1.2 Bayer AG

      3. 6.1.3 Bristol Myers Squibb Company

      4. 6.1.4 F. Hoffmann-La Roche

      5. 6.1.5 Amgen Inc.

      6. 6.1.6 Merck & Co. Inc.

      7. 6.1.7 Novartis International AG

      8. 6.1.8 Pfizer Inc.

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Middle East and Africa (MEA) Kidney Cancer Therapeutics & Diagnostics Market market is studied from 2018 - 2026.

The Middle East and Africa (MEA) Kidney Cancer Therapeutics & Diagnostics Market is growing at a CAGR of 5.2% over the next 5 years.

Bayer AG, F. Hoffmann-La Roche, Bristol Myers Squibb Company, Abbott Laboratories, Amgen Inc. are the major companies operating in Middle East and Africa (MEA) Kidney Cancer Therapeutics & Diagnostics Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!